Co-Diagnostics surges on capital raise.

Co-Diagnostics surges on capital raise. CODX announced a private placement agreement to sell 1.65 million shares of common stock alongside warrants to purchase 3.29 million additional shares to institutional investors. The company raised approximately three million dollars through this offering. The stock jumped eleven percent following the announcement, reflecting positive market sentiment toward the financing. Private placements like this provide companies with capital for operations and growth initiatives while giving institutional investors equity upside through warrant provisions. Co-Diagnostics, a molecular diagnostics company, continues to strengthen its balance sheet amid ongoing market dynamics in the diagnostic testing sector.